
Deals & Capital Markets
Pfizer Licenses Novavax's Matrix-M Adjuvant for Up to $530M
Jan 20
You're signed outSign in or to get full access.
Browse executives, board members, and key leadership.

Chief Executive Officer
Chief U.S. Commercial Officer
Chief Strategy and Innovation Officer
Chief Scientific Officer and President, Research & Development
Chief Financial Officer
Chief Global Supply and Quality Officer
Director
Director
Director
Director
Director
Director
Director
Director
Lead Independent Director
Director
Director
Director



